The presence of iMSCs was confirmed by in situ immunofluorescence staining for IL-1R1 in FFPE BM tissue, revealing higher IL-1R1+ cell counts in MDS compared to Control and CHIP donors (Fig. 3F, G). Here, IL1R1 is linked to myelodysplastic syndrome.